This document discusses adverse outcome pathways (AOPs) and efforts to develop them. It outlines that AOPs can improve toxicity predictions, inform species extrapolation, identify data gaps, and provide targets for screening assays. Challenges include limited coverage of biological space by current AOPs. Efforts are underway for collaborative AOP development through a wiki platform and computational approaches. Integrating multiple pathways and accounting for non-linear biology is important. The talk promotes further developing AOPs to further toxicity assessments.